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Introduction: Previous studies have suggested that high volume hemofiltration (HVHF) may contribute to revert
hypotension in severe hyperdynamic septic shock patients. However, arterial pressure stabilization occurs due to an
increase in systemic vascular resistance, which could eventually compromise microcirculatory blood flow and
perfusion. The goal of this study was to determine if HVHF deteriorates sublingual microcirculation in severe
hyperdynamic septic shock patients.
Methods: This was a prospective, non-randomized study at a 16-bed, medical-surgical intensive care unit of a
university hospital. We included 12 severe hyperdynamic septic shock patients (norepinephrine requirements > 0.3 μg/
kg/min and cardiac index > 3.0 L/min/m2) who underwent a 12-hour HVHF as a rescue therapy according to a
predefined algorithm. Sublingual microcirculation (Microscan for NTSC, Microvision Medical), systemic hemodynamics
and perfusion parameters were assessed at baseline, at 12 hours of HVHF, and 6 hours after stopping HVHF.
Results: Microcirculatory flow index increased after 12 hours of HVHF and this increase persisted 6 hours after
stopping HVHF. A similar trend was observed for the proportion of perfused microvessels. The increase in
microcirculatory blood flow was inversely correlated with baseline levels. There was no significant change in
microvascular density or heterogeneity during or after HVHF. Mean arterial pressure and systemic vascular
resistance increased while lactate levels decreased after the 12-hour HVHF.
Conclusions: The use of HVHF as a rescue therapy in patients with severe hyperdynamic septic shock does not
deteriorate sublingual microcirculatory blood flow despite the increase in systemic vascular resistance.
Introduction
High-volume hemofiltration (HVHF) is a potential res-
cue therapy in patients with severe septic shock, and
some clinical studies suggest that HVHF can decrease
vasopressor requirements and improve lactate clearance
[1,2]. Therefore, HVHF may have a place in refractory
septic shock by contributing to the stability of systemic
hemodynamics and eventually improving systemic perfu-
sion. However, studies supporting HVHF are rather
small and non-randomized, and this prevents investiga-
tors from drawing a more definitive conclusion about its
real impact on clinically relevant outcomes. Indeed,
decreases in vasopressor requirements and lactate levels
may not necessarily reflect a real improvement in perfu-
sion. In the past, therapies such as steroids and nitric
oxide synthase inhibitors have been shown to increase
vascular tone without any significant benefit in terms of
perfusion or survival [3,4]. In addition, it is now well
accepted that hyperlactatemia may be explained by
mechanisms not related to hypoperfusion [5]. Clearly, it
would be desirable to assess the impact of HVHF on
perfusion determinants (particularly, on microcircula-
tion) more directly.
The development of optical techniques such as ortho-
gonal polarized spectral imaging and, more recently,
side dark field videomicroscopy (SDF) has made it possi-
ble to visualize microcircirculation at the bedside.
Microcirculation is known to be markedly compromised
during septic shock and these disturbances are consid-
ered to play a central role in multiple organ failure. By
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tional therapies on microcirculation is starting to be
unraveled [6-9].
There is very limited information concerning the
potential effects of HVHF on microcirculation during
septic shock. Only one previous experimental study has
addressed this subject [10], but unfortunately, the model
induced only non-severe microcirculatory derangements,
making the results difficult to interpret. Beneficial effects
of HVHF have been related to non-specific removal of
mediators, which could potentially contribute to the
reversion of microcirculatory disturbances induced by
sepsis. However, the most evident clinical effect of
HVHF is an increase in arterial pressure, and this occurs
as a result of an increased systemic vascular resistance,
and not of an increase in cardiac output, at least in
hyperdynamic patients [2]. Therefore, it is critical to
determine whether this increase in vascular resistance is
associated with a detrimental effect on microcirculatory
flow. We performed a prospective observational pilot
study to assess changes in sublingual microcirculation
during HVHF in patients with severe hyperdynamic sep-
tic shock.
Materials and methods
Our local ethics committee approved the study, and
informed consent was obtained from the patients or
their relatives. All septic shock patients in our institu-
tion are managed with a norepinephrine-based, perfu-
sion-oriented management algorithm. Septic patients
presenting a circulatory dysfunction at the emergency
department or the pre-intensive care unit (pre-ICU) are
subjected to vigorous fluid resuscitation followed by
central venous catheter insertion and basal measure-
ments of lactate (Radiometer ABL 735; Radiometer,
Brønshøj, Denmark) and central venous oxygen satura-
tion (ScvO2). Patients who develop persistent hypoten-
sion or hyperlactatemia are transferred promptly to the
ICU. The algorithm involves early aggressive source
control and fluid loading followed by norepinephrine,
which is adjusted to keep a mean arterial pressure
( M A P )o fa tl e a s t6 5m mH g .F l u i dr e s u s c i t a t i o ni s
guided by pulse pressure variation (if the patient is
already on mechanical ventilation) or by central venous
pressure. Pulse pressure variation (ΔPP) is calculated as
ΔP P=1 0 0×( P P max -P P min)/[(PPmax -P P min)/2]. If
after fluid optimization norepinephrine is greater than
0.3 μg/kg per min, patients are characterized as having
severe septic shock. At this stage, all patients must have
a pulmonary artery catheter in place and be sedated and
connected to mechanical ventilation. Mechanical ventila-
tion and sedation are managed in accordance with cur-
rent protective strategies [11]. Dobutamine is indicated
as an inotrope for patients with low cardiac index (CI)
(less than 2.5 L/min per m
2)o rl o wS c v O 2 or mixed
venous oxygen saturation (SmvO2) values (less than
60%) not responsive to other measures and with an
MAP of greater than 65 mm Hg. HVHF is indicated for
patients who fail to respond to all preceding manage-
ment steps, including source control and fluid optimiza-
tion guided by ΔPP [2,12].
Specific inclusion criteria for this study were septic
shock according to the 1992 ACCP-SCCM (American
College of Chest Physicians/Society of Critical Care
Medicine) consensus [13], norepinephrine requirements
of at least 0.3 μg/kg per min to maintain an MAP of
greater than 65 mm Hg for at least 1 hour before decid-
ing HVHF, progressive hyperlactatemia (greater than
2.4 mmol/L and an increase in lactate levels during
4 hours of full resuscitation), and a CI of at least 3 L/
min per m
2. Patients without full commitment for resus-
citation or with active bleeding or an undrained source
of surgical sepsis were excluded.
All patients had a pulmonary artery catheter in place
and were mechanically ventilated following current
guidelines [11], with fentanyl/midazolam sedation tar-
geted to a Sedation-Agitation Scale (SAS) score of less
than 3. No patient received steroids, vasopressin, or dro-
trecogin alpha either before or during the hemofiltration
procedure. Blood transfusions were indicated before the
procedure if the hemoglobin value was less than 8 g/dL.
High-volume hemofiltration technique
A 13.5-french double-lumen hemodialysis catheter was
inserted in the femoral vein under local anesthesia
(Q-plus; Covidien, Mansfield, MA, USA). HVHF was per-
formed with a polysulfone hemofilter that had an area of
1.5 m
2, a wall thickness of 40 μm, and an internal dia-
meter of 200 μm (Diacap acute-M; B. Braun, Melsungen,
Germany). The hemofiltration monitor was adjusted
for a blood flow of 200 mL/min. During the first 60 min-
utes, the ultrafiltration rate was increased gradually
to 100 mL/kg per hour according to hemodynamic toler-
ance while always keeping a neutral fluid balance
(Diapac; B. Braun). Pre-hemofilter ultrafiltrate reposition
was performed using a bicarbonate-based solution with
the following final composition: sodium 140.0 mmol/L,
potassium 2.0 mmol/L, calcium 1.5 mmol/L, magnesium
0.5 mmol/L, chloride 111 mmol/L, bicarbonate 35 mmol/
L, and dextrose 1 g/L and an osmolality of 296 mOsm/L
(S-BIC 35 and SH-EL 02; B. Braun Avitum AG, Glandorf,
Germany). The extracorporeal system was not anticoagu-
lated, and patient core temperature was kept over 35°C
by the heating device coupled to the monitor and by
warming the solutions when necessary. According to our
ICU protocol [2], all patients were scheduled to receive a
12-hour period of HVHF with a single hemofilter, during
which additional fluids and the norepinephrine dose were
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ΔPP of less than 10%. Before the start of the procedure,
all patients should have a ΔPP of less than 10%.
Measurements
Patients were assessed before starting HVHF (baseline),
after 12 hours of HVHF, and 6 hours after stopping
HVHF. Each assessment consisted of hemodynamic
measurements (MAP, heart rate, CI, pulmonary artery
occlusion pressure, and central venous pressure),
vasoactive requirements, perfusion parameters (arterial
lactate, SmvO2, and urine output), Sequential Organ
Failure Assessment (SOFA) score, and sublingual micro-
circulation imaging.
Sublingual microcirculation imaging
Sublingual microcirculation was assessed with SDF with
a 5× lens (MicroScan(r) for NTSC [National Television
System Committee]; MicroVision Medical, Amsterdam,
The Netherlands). At each time point, at least five 10-
to 20-second images were recorded. After saliva and
oral secretions were gently removed, the probe was
applied over the mucosa at the base of the tongue. Spe-
cial care was taken to avoid exerting excessive pressure
on the mucosa, and this was verified by checking
ongoing flow in the larger microvessels (greater than 50
μm). Analog images were digitalized by using the pass-
through function of a digital video camera recorder
(Sony DCR-HC96 for NTSC; Sony Corporation, Tokyo,
Japan) and were recorded instantaneously in AVI format
on a personal computer with the aid of commercial soft-
ware (DVGate Plus 2.3; Sony Corporation).
Images were analyzed blindly and randomly using a
semiquantitative method. According to recommenda-
tions of a consensus committee [14], the image analy-
sis consisted of determinations of (a) flow: proportion
of perfused vessels (PPV) and microvascular flow index
(MFI); (b) density: total vascular density (TVD) and
perfused vascular density (PVD); and (c) heterogeneity:
MFI heterogeneity (Het MFI). Briefly, to determine
MFI, the image was divided in four quadrants and the
predominant type of flow was assessed in each quad-
rant and characterized as absent = 0, intermittent = 1,
sluggish = 2, or normal = 3; the values of the four
quadrants were averaged. MFI heterogeneity was calcu-
lated as Het MFI = (MFImax -M F I min) × 100/MFImean.
For TVD and PVD, a gridline consisting of three hori-
zontal and three vertical equidistant lines was superim-
posed on the image. All of the vessels crossing the
lines were counted and classified as perfused vessels
(continuous flow) or non-perfused vessels (absent or
intermittent flow, the latter of which is the absence of
flow for at least 50% of the time). Densities were cal-
culated as the total number of vessels (TVD), or the
number of perfused vessels (PVD), divided by the total
length of the gridline in millimeters. PPV was calcu-
lated as PVD × 100/TVD (percentage). Large and
small (less than 20 μm) vessels were analyzed sepa-
rately. According to recommendations from experts
[14], the analysis of large vessels is of limited interest,
and in this study they were used as a quality control to
ensure that no excessive pressure was being applied on
the sublingual mucosa. Therefore, all of the data from
sublingual microcirculation presented correspond to
small vessels.
Statistical analysis
Data with normal distribution are presented as mean ±
standard deviation, and data not normally distributed
are presented as median and 25th-75th percentiles.
Repeated measures analysis of variance with the Bonfer-
roni post hoc test was used to evaluate changes along
time for normally distributed data, and the Friedman
test with Dunn test correction was used for variables
without normal distribution. Correlations were deter-
mined by the Pearson coefficient or Spearman’sr h of o r
data with normal and non-normal distributions, respec-
tively. Analysis was performed with GraphPad Prism
version 5.00 for Windows (GraphPad Software, La Jolla,
CA, USA). A two-sided P v a l u eo fl e s st h a n0 . 0 5w a s
considered statistically significant.
Results
Twelve consecutive patients with severe hyperdynamic
septic shock (seven men and five women, 57.9 ± 13.2
years old) were recruited between March 2007 and
March 2009. Baseline characteristics are presented in
Table 1. The more common sources were abdominal in
five and pulmonary in two. All patients started HVHF
less than 6 hours after meeting the inclusion criteria.
One patient had a baseline norepinephrine requirement
of 0.28 μg/kg per minute, but he had met the norepi-
nephrine inclusion criteria during the screening period
(specifically, a norepinephrine dose of greater than 0.3
μg/kg per minute for more than 1 hour with a ΔPP of
less than 10%). Baseline assessment was performed just
before the start of HVHF. Only two patients were
receiving dobutamine for at least 2 hours before the
start of HVHF, and its dose was not changed during the
procedure (patients 1 and 6). All patients survived until
the end of the study period, but five patients died at day
28 (42%). No technical problems with the procedure
were observed and no change of hemofilter was required
in any patient.
Hemodynamic and perfusion parameters
MAP and systemic vascular resistance index (SVRI)
increased and lactate levels decreased at 12 hours of
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transport, and O2 consumption did not change during
or after HVHF (Table 2).
Microcirculatory parameters
Density scores (TVD and PVD) and Het MFI did not
show any significant variation during the study
(Figure 1 and Table 2). MFI significantly increased
compared with baseline after 12 hours of HVHF and
did not deteriorate after HVHF was stopped. In paral-
lel, there was a trend to increased PPV during HVHF
(Figure 2 and Table 2). Interestingly, three of the four
patients with the worst MFI (less than 2) had a signifi-
cant improvement after 12 hours of HVHF.
Table 1 Baseline characteristics of patients at the start of high-volume hemofiltration

















1 Cholangitis 34 13 Yes 70 0.30 3 49 6
2 Necrotizing
fasceitis
24 10 Yes 67 0.56 5.5 79 4.7
3 Cholangitis 25 11 Yes 65 0.50 5.3 76 8.3
4 Catheter
related sepsis
31 15 No 70 0.60 3.1 71 4.1
5 Diverticulitis 19 14 Yes 75 0.37 5.5 80 2.6
6 Peritonitis 19 11 No 64 0.30 4.4 61 6.7
7 Pneumonia 21 13 Yes 74 0.50 3.1 58 2.6
8 Necrotizing
fasceitis
25 13 No 64 1.00 4.8 79 4.5
9 Pyonephrosis 23 13 Yes 66 0.28 3.5 71 3.6
10 Mesenteric
ischemia
23 13 Yes 62 0.62 3.4 78 2.6
11 Empyema 27 14 No 63 0.30 4.8 96 13
12 Endocarditis 25 15 No 70 0.60 3 70 5.8
Mean 24.7 12.8 67.5 0.49 4.1 72 5.4
SD 4.4 1.7 4.3 0.21 1.0 11 3.0
APACHE II, Acute Physiology and Chronic Health Evaluation II; CI, cardiac index; MAP, mean arterial pressure; NE, norepinephrine; SD, standard deviation; SmvO2,
mixed venous oxygen saturation; SOFA, Sequential Organ Failure Assessment.
Table 2 Evolution of microcirculatory scores and hemodynamic and perfusion parameters during the study
Parameter Baseline After 12 hours of HVHF 6 hours after HVHF
MAP, mm Hg 67.5 ± 4.3 74.5 ± 6.8
a 76.0 ± 9.4
a
Norepinephrine, μg/kg per min 0.49 ± 0.21 0.44 ± 0.45 0.26 ± 0.38
CI, L/min per m
2 4.06 ± 1.11 3.68 ± 1.36 3.55 ± 1.12
SmvO2, percentage 72.4 ± 1.7 71.4 ± 7.0 76.1 ± 6.0
Lactate, mmol/L 5.38 ± 2.99 3.66 ± 2.39
a 3.64 ± 3.89
a
IDO2, mL/min per m
2 543 ± 211 483 ± 350 475 ± 173
IVO2, mL/min per m
2 137 ± 63 135 ± 101 108 ± 40
O2ER, percentage 26 ± 12.3 27.8 ± 0.7 23.1 ± 6.0
SVRI, dyne-s/cm
5 per m
2 1,027 ± 268 1,373 ± 408
b 1,432 ± 375
b
Hemoglobin, g/dL 10.1 ± 1.4 10.2 ± 2 10.2 ± 1.3
Core temperature, °C 38.1 ± 1 37.2 ± 0.9 37.5 ± 1.1
SOFA score 12.8 ± 1.7 13.1 ± 2.1 12.4 ± 2.5
TVD, n/mm 13.1 ± 1.9 13.6 ± 3.3 14.2 ± 3.8
PVD, n/mm 9.6 ± 2.5 11.1 ± 3.0 12.1 ± 4.3
PPV, percentage 73.6 ± 15.6 81.7 ± 13.3
c 83.2 ± 14.7
c
MFI




d 0.44 (0.36-0.47) 0.4 (0.12-0.65) 0.29 (0.18-0.32)
aP < 0.05 versus baseline;
bP < 0.01 versus baseline;
cP < 0.06 versus baseline;
ddata are presented as mean ± standard deviation or as median and 25th-75th
percentiles. CI, cardiac index; Het MFI, heterogeneity of microvascular flow index; HVHF, high-volume hemofiltration; IDO2, oxygen delivery index; IVO2, oxygen
consumption index; MAP, mean arterial pressure; MFI, microvascular flow index; n/mm, number of vessels per millimeter; O2ER, oxygen extraction ratio; PPV,
proportion of perfused vessels; PVD, perfused vascular density; SmvO2, mixed venous oxygen saturation; SOFA, Sequential Organ Failure Assessment; SVRI,
systemic vascular resistance index; TVD, total vascular density.
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at baseline and the relative changes occurring during
the 12-hour HVHF. For PVD and PPV, there was a
strong negative correlation such that patients with the
worst scores at baseline had the largest improvements
during the 12-hour HVHF (Figure 3). For TVD, MFI,
and Het MFI, there was no significant correlation
between baseline values and their relative changes dur-
ing HVHF. In addition, we looked at correlations
between microcirculatory changes and changes in hemo-
dynamic and perfusion parameters (Table 3). There was
no significant correlation.
Discussion
In the present study, we found no deterioration of sub-
lingual microcirculation during HVHF, despite an
increase in systemic vascular resistance in patients with
severe hyperdynamic septic shock. Furthermore, micro-
circulatory flow index significantly improved during
HVHF, whereas PPV showed the same trend, which did
not reach statistical significance. These effects seem to
be more marked in patients with more impaired basal
microcirculation.
Several experimental and clinical studies have sug-
gested that HVHF can be an effective rescue therapy in
refractory septic shock, stabilizing hemodynamics,
decreasing vasopressor requirements, and improving lac-
tate clearance [1,2,15]. This is the first study that
explores the effects of HVHF on microcirculation in
patients with septic shock. We observed an increase in
sublingual microcirculatory blood flow during HVHF.
Interestingly, this increase occurred despite an increase
in SVRI and a trend to decreased cardiac output. One
Figure 1 Effects of high-volume hemofiltration (HVHF) on
sublingual microvascular density. The graphs present the
individual evolution of total vascular density (upper graph) and
perfused vascular density (lower graph) of small vessels (< 20 μm)
at baseline, at the end of the 12-hour period of HVHF, and 6 hours
after stopping HVHF. There was no significant change. Density is
expressed as the number of vessels divided by the total length of
the gridline in millimeters.
Figure 2 Effects of high-volume hemofiltration (HVHF) on
sublingual microvascular flow. The graphs present the individual
evolution of flow assessed by the percentage of perfused vessels
(upper graph) and by the microvascular flow index (lower graph) of
small vessels (< 20 μm) at baseline, at the end of the 12-hour
period of HVHF, and 6 hours after stopping HVHF. *P < 0.05
compared with baseline.
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alterations in sepsis is the presence of shunt. The obser-
vation of increasing microcirculatory blood flow paral-
leled by increasing vascular resistance and decreasing
cardiac output may be explained by a reversal of shunt.
The underlying mechanisms involved in the changes
observed on hemodynamics and microcirculation are
unclear. HVHF may remove some inflammatory media-
tors involved in the hemodynamic collapse of refractory
septic shock from the blood compartment or the extra-
vascular space [16]. Owing to its broad theoretical phy-
siologic effects, HVHF could potentially influence
several microcirculatory parameters and improve micro-
circulatory derangements in septic shock. However,
because of the uncontrolled design of our study, we can-
not rule out that changes observed on hemodynamics
and microcirculation were not related to HVHF. The
changes might correspond to the natural evolution of
septic shock after initial resuscitation, as shown by Sakr
and colleagues [17], or occur as the result of other coin-
terventions such as ongoing fluids or a strict hemody-
namic management.
There has been controversy about the role of systemic
hemodynamic variables on microcirculation [18,19].
Theoretically, arterial pressure could influence microcir-
culatory flow if autoregulation is altered, or norepi-
nephrine could induce a decrease in microcirculatory
flow secondary to vasoconstriction. Trzeciak and collea-
gues [19] found a positive correlation between MAP and
sublingual microcirculatory blood flow in septic shock
patients during the early phase of resuscitation. How-
ever, two elegant physiologic studies performed in septic
shock patients have shown that arterial pressure changes
induced by changing norepinephrine doses do not influ-
ence sublingual MFI across a large range of arterial
pressures and norepinephrine doses [20,21]. In the pre-
sent study, MAP increased from 67.5 ± 4.6 mm Hg at
baseline to 74.5 ± 6.8 mm Hg at 12 hours of HVHF, but
we found no significant correlation between changes in
MAP and changes in MFI during the 12-hour HVHF.
We also looked for correlations between changes in
other systemic hemodynamic variables and changes in
sublingual microcirculation during HVHF and found no
significant correlation. Therefore, our data do not sup-
port the possibility that the increase in MFI observed
was induced by changes in systemic hemodynamics.
Previously, an elegant experimental study compared
the effects of standard hemofiltration versus HVHF in a
porcine model of hyperdynamic sepsis [10]. Although
Figure 3 Relationship between baseline sublingual
microcirculatory parameters and their change during the 12-
hour high-volume hemofiltration (HVHF). The upper graph shows
a significant correlation between baseline values of perfused vascular
density (PVD) and their variation during the 12-hour HVHF. The lower
graph shows a similar correlation between the baseline values of the
percentage of perfused vessels (PPV) and their variation during the
12-hour HVHF. Both PVD and PPV were calculated for small vessels
(< 20 μm). Density is expressed as the number of vessels divided by
the total length of the gridline in millimeters.
Table 3 Correlations between variations in microcirculatory scores observed during high-volume hemofiltration and
variations in systemic hemodynamic and organ dysfunction parameters
MAP NE Lactate CI SmvO2 IDO2 IVO2 O2ER SVRI SOFA
TVD −0.01 0.25 0.34 −0.14 0.31 0.12 0.10 −0.09 0.10 0.23
PVD 0.18 0.22 0.30 −0.08 0.22 0.13 0.12 −0.06 0.01 0.40
PPV 0.24 0.02 0.30 0.06 0.27 0.15 −0.15 −0.16 0.09 0.47
MFI 0.40 −0.03 0.25 0.24 −0.01 −0.02 0.17 −0.09 −0.13 0.37
Variations for each parameter were calculated as the difference between values at 12 hours of high-volume hemofiltration and values at baseline. Data
correspond to correlations (r values) obtained either by Pearson coefficient (total vascular density [TVD], perfused vascular density [PVD], and proportion of
perfused vessels [PPV]) or by Spearman’s rho (microcirculatory flow index [MFI]). None of the correlations was statistically significant. CI, cardiac index; IDO2,
oxygen delivery index; IVO2, oxygen consumption index; MAP, mean arterial pressure; NE, norepinephrine; O2ER, oxygen extraction ratio; SmvO2, mixed venous
oxygen saturation; SOFA, Sequential Organ Failure Assessment; SVRI, systemic vascular resistance index.
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hemodynamics, no beneficial effect on microcirculatory
flow, hepatosplanchnic hemodynamics, cellular ener-
getics, endothelial injury, or systemic inflammation
could be observed. Unfortunately, the model induced
only mild to moderate disturbances in hemodynamics
and microcirculatory flow and therefore the condition
did not represent severe septic shock.
Until now, only a few uncontrolled small studies have
evaluated the hemodynamic effects of HVHF in patients
with septic shock. Honore and colleagues [1] showed
that HVHF responders improved cardiac output and
systemic hemodynamics in a series of patients with
hypodynamic septic shock. In our previous report invol-
ving only patients with hyperdynamic septic shock [2],
we found that MAP increased mainly because of an
increase in SVRI. However, an improvement in MAP at
the expense of an increase in SVRI may not necessarily
be beneficial in terms of microcirculatory flow [21], per-
fusion parameters [22], or survival [4]. The non-selective
nitric oxide synthase inhibitor 546C88 induced a strong
pressor effect in patients with septic shock, but unfortu-
nately this effect was associated with higher incidences
of pulmonary hypertension, systemic arterial hyperten-
sion, and heart failure; a decreased cardiac output; and a
higher mortality [4]. Therefore, our results may be rele-
vant since they suggest that the potential beneficial
hemodynamic effect of HVHF i sn o ta tt h ee x p e n s eo f
microcirculatory flow.
It is rather surprising that only 4 of 12 patients exhi-
biting severe septic shock presented the low MFI of less
than 2. This observation is consistent with recent data
from Dubin and colleagues [20] and Jhanji and collea-
gues [21], who found mean basal MFI values of 2.1 ±
0.7 and 2.3 ± 0.4, respectively. In fact, in the former
study, only 4 of 22 patients with septic shock exhibited
an MFI of less than 2. This is in sharp contrast with the
data of Trzeciak and colleagues [19], who reported MFI
values of less than 1.5 early after emergency room
or ICU admission. It appears that MFI values, resembling
what happens with ScvO2, are very low in pre-
resuscitated patients but may improve after aggressive
resuscitation, except in refractory patients who are dying.
We found a negative correlation between the severity
of basal microcirculatory derangements and their change
after a 12-hour HVHF session. Similar observations have
been reported by other authors when studying the effect
of different interventions on microcirculatory dysfunc-
tion in septic patients. Dubin and colleagues [20]
assessed the effects of increasing MAP over microcircu-
latory dysfunction and found that changes in perfused
capillary density correlate inversely with basal values.
Sakr and colleagues [17] showed that changes in capil-
lary perfusion after red blood cell transfusion correlate
negatively with baseline capillary perfusion. At this
moment, we have no clear explanation for these find-
ings, but it appears that different interventions aimed at
improving microcirculatory flow may be more effective
in patients with more severe basal derangements.
The present study has several limitations. First, it
includes a small number of patients. In our current septic
shock management algorithm, HVHF is a rescue therapy.
As reported elsewhere [12], the strict application of our
protocol has led to an improvement in outcome, and
therefore only 20% of septic shock patients are eligible for
this intervention. Since only hyperdynamic septic shock
patients with norepinephrine requirements of at least
0.3 μg/kg per minute and progressive hyperlactatemia
were included in this study, we recruited only 1 patient
every 45 days. This fact precluded the inclusion of a larger
number of patients. Second, we did not include a control
group. This limitation is shared by several studies addres-
sing the impact of conventional therapies on microcircula-
tion [6-8,23]. In our case, this was an observational pilot
study and therefore a control group was not considered.
However, we acknowledge the advantage of having a con-
trol group for future studies. In fact, the only randomized
controlled trial involving microcirculatory dysfunction,
which compared nitroglycerin versus placebo in patients
with septic shock, found that MFI improved over time in
both groups in the setting of a strict-background com-
mon-resuscitation protocol [9]. Third, our study protocol
considered microcirculatory reassessment only after
completing the standard 12-hour HVHF procedure, and
thus we could have missed earlier effects. We selected a
12-hour design for two reasons: (a) the first couple of
hours after starting HVHF are characteristically unstable,
and patients are subjected to frequent fluid challenges or
vasopressor titration that preclude a clear interpretation of
microcirculatory changes; and (b) we were interested in
evaluating the full effect of a 12-hour pulse HVHF session.
Finally, it is still unclear whether the sublingual microcir-
culation is representative of other organs [24,25], so addi-
tional studies are necessary to assess the impact of HVHF
over other microvascular beds.
Conclusions
The use of HVHF as a rescue therapy in patients with
severe hyperdynamic septic shock is not associated with
deterioration of sublingual microcirculation, despite the
increase in systemic vascular resistance. For the clini-
cian, this suggests that the arterial pressure and SVRI
increases that are usually observed during HVHF are
not at the expense of microcirculation. Furthermore,
patients with the lowest values of sublingual microcircu-
latory blood flow seem to improve in this respect during
HVHF. However, randomized controlled studies with
HVHF in septic shock are required to confirm and
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dynamics and perfusion.
Key messages
￿ During high-volume hemofiltration in patients with
hyperdynamic septic shock, there is no deterioration
of sublingual microcirculation, despite an increase in
systemic vascular resistance.
￿ Sublingual microcirculatory blood flow may even
increase during high-volume hemofiltration.
￿ Septic shock patients with the lowest values of
sublingual microcirculatory blood flow at baseline
exhibit a more pronounced improvement during
high-volume hemofiltration.
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